Product NDC: | 25021-826 |
Proprietary Name: | zoledronic acid |
Non Proprietary Name: | zoledronic acid |
Active Ingredient(s): | .04 mg/mL & nbsp; zoledronic acid |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | LIQUID |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 25021-826 |
Labeler Name: | Sagent Pharmaceuticals |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA203231 |
Marketing Category: | ANDA |
Start Marketing Date: | 20130302 |
Package NDC: | 25021-826-82 |
Package Description: | 1 BAG in 1 CARTON (25021-826-82) > 100 mL in 1 BAG |
NDC Code | 25021-826-82 |
Proprietary Name | zoledronic acid |
Package Description | 1 BAG in 1 CARTON (25021-826-82) > 100 mL in 1 BAG |
Product NDC | 25021-826 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | zoledronic acid |
Dosage Form Name | LIQUID |
Route Name | INTRAVENOUS |
Start Marketing Date | 20130302 |
Marketing Category Name | ANDA |
Labeler Name | Sagent Pharmaceuticals |
Substance Name | ZOLEDRONIC ACID |
Strength Number | .04 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Bisphosphonate [EPC],Diphosphonates [Chemical/Ingredient] |